
Journal of Medicinal Chemistry p. 4195 - 4204 (1992)
Update date:2022-08-03
Topics:
Deal, Martyn J.
Hagan, Russell M.
Ireland, Simon J.
Jordan, Christopher C.
McElroy, Andrew B.
et al.
The design and synthesis of potent and selective neurokinin NK-2 receptor agonists 12 (GR64349) and 31 are described, together with structure-activity relationships for related analogues.Compound 12 (EC50 = 3.7 nM at NK-2 receptors in the rat colon; selectivity >1000- and >300-fold with respect to NK-1 and NK-3 receptors, respectively) was derived by incorporation of a Gly-Leu γ-lactam conformational constraint into the C-terminal region of the neurokinin A octapeptide analogue
Tianjin Te-An Chemtech Co., Ltd.(expird)
Contact:+86-22-65378638
Address:A5-8, No.80 Haiyun Street, TEDA
Zhengzhou Institute of Chiral Pharmer Research Co., Ltd.
Contact:86-371-55219111
Address:15 Floor, 2 Building, Central China Technovalley, Zhongyuan West Road
QINGDAO ON-BILLION INDUSTRAIL CO.,LTD
website:http://www.obn.com.cn
Contact:+86-15005320811 +86-532-80681989
Address:F35 Parkson Mansion No.44-60 Zhongshan Rd.
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Ningxia Soochow Agrochemical Limited Company
Contact:(+86)0512 6320 8190
Address:wujiang
Doi:10.1002/hlca.19750580418
(1975)Doi:10.1016/S0040-4020(01)88305-8
(1992)Doi:10.1016/S0040-4039(00)74815-5
(1992)Doi:10.1016/j.molliq.2013.01.013
(2013)Doi:10.1021/jo4005684
(2013)Doi:10.1055/s-1992-26201
(1992)